![]() |
市場調查報告書
商品編碼
1827754
2025年全球醫用人工材料市場報告Medical Engineered Materials Global Market Report 2025 |
近年來,醫療義肢材料市場快速擴張,市場規模將從2024年的221.2億美元成長至2025年的252.4億美元,複合年成長率為14.1%。預測期內的成長歸因於人口老化、法規遵循、感染控制、植入材料和組織工程。
預計未來幾年醫療義肢材料市場將快速成長,到2029年將達到431.8億美元,年複合成長率(CAGR)為14.4%。預測期內的成長可歸因於全球衛生防備、3D列印和積層製造、先進塗層、奈米醫學和個人化醫療。預測期內的主要趨勢包括奈米技術、可生物分解和可吸收材料、生物活性智慧材料、永續性和環保材料以及醫療技術的進步。
醫學工程材料,通常稱為生物材料,是經過特殊設計的物質,旨在滿足特定或客製化的標準,與生物系統相互作用,用於醫療領域的治療或診斷。這些材料在科學、技術和醫學的交叉領域中發揮關鍵作用,其應用將材料科學的關鍵要素與對醫學設計的深刻理解相結合。
醫療工程材料的主要類別包括醫用塑膠、醫用泡棉、醫用薄膜、醫用黏合劑和醫用彈性體。醫用級塑膠材料用於製造醫療用品。這些材料用於製造體外診斷產品和藥品的初級包裝,確保藥品的保存和密封,防止污染。應用範圍包括醫療設備、一次性醫療用品、醫用穿戴式裝置和進階傷口護理。
2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響,尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要重新認證醫療設備,導致市場進入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供醫療義肢材料市場統計數據,例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的醫療義肢材料細分市場、市場趨勢和商機,以及您在醫療義肢材料行業取得成功所需的數據。本醫療義肢材料市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的一切觀點。
我們預測未來五年該市場將成長14.4%,較我們先前對該市場的預測略有下降0.2%。下降的主要原因是美國與其他國家之間關稅的影響。美國對瑞士生物相容性鈦和聚醚醚酮 (PEEK) 聚合物徵收的關稅上調,直接影響了美國,並可能減緩植入和假體的生產,同時推高醫療成本。此外,由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,這種影響也將更加廣泛地顯現。
慢性病的預期成長將推動醫療義肢材料市場的成長。慢性病的特徵是病程長達一年以上,需要持續治療,且日常活動受限,這推動了對奈米級設計材料的需求。奈米工程組件可用於建構心腔的微型複製品,為治療心臟相關疾病提供創新解決方案。根據美國國家生物技術資訊中心 (NCBI) 2023 年 1 月的報告,預計到 2050 年,全球慢性病患者人數將達到 1.4266 億,較 2020 年的 7152.2 萬人大幅增加。慢性病的增加將成為醫療義肢材料市場成長的催化劑。
預計外科手術數量的增加將推動醫療義肢材料市場的成長。外科手術是指需要切口或侵入性技術來進入和治療身體內部或外部區域的醫療干預措施。外科手術數量的激增推動了對手術器械、植入式器械以及微創手術所用材料的需求。對生物相容性和抗感染材料的迫切需求凸顯了它們在確保病人安全方面的關鍵作用。由客製化和監管標準驅動的研發,以及由成本效益和技術進步驅動的材料創新,正在推動醫療義肢材料市場的成長。例如,經濟合作暨發展組織)在 2023 年 10 月報告稱,捷克共和國的白內障手術數量將從 2021 年的 131,612 例增加 8.4%,到 2022 年將達到 142,670 例。因此,外科手術數量的增加將成為醫療義肢材料市場的成長動力。
醫療義肢材料市場的主要企業正在策略性地推出新產品,以增強其競爭地位。例如,美國特種材料公司塞拉尼斯公司於2022年5月推出了Celanex MT PBT 2406MT GF20。這款高性能材料專為醫療設備和各種應用而設計,具有卓越的強度、剛性和無噪音的滑動性能。其應用範圍包括I類、II類和III類醫療設備,以及汽車、電氣和電子設備、工業機械和消費品。這款摩擦改質PBT+PET牌號,採用20%的玻璃纖維增強,可為各行各業提供多功能解決方案。
醫療義肢材料市場的主要企業正在投資新產品開發,以獲得競爭優勢。總部位於德國的聚合物材料公司科思創股份公司於2023年2月推出了Makrolon 3638聚碳酸酯。這款先進的材料解決方案專為醫療保健和生命科學應用量身定做,在從低溫到蒸氣滅菌的廣泛溫度範圍內均具有高耐久性。它具有高抗衝擊強度、延展性和耐化學性,符合醫療級和生物相容性標準。該材料適用於皮膚接觸應用,也具有食品接觸級質量,並可使用醫療保健領域常用的方法進行滅菌。
2022年2月,總部位於美國的全球工業領導者塞拉尼斯公司以110億美元完成了對杜邦樹脂和先進解決方案業務線的收購。這項戰略舉措預計將使塞拉尼斯憑藉其無與倫比的規模、生產能力和技術專長,成為汽車、消費品和工業市場的市場領導。杜邦是一家從事醫療工程材料業務的美國公司,也參與了這項收購。
醫療工程材料市場的主要企業包括贏創工業股份公司、科思創股份公司、BASF股份公司、索爾維股份公司、沙烏地基礎工業公司、特瑞堡股份公司、荷蘭皇家帝斯曼集團、塞拉尼斯公司、杜邦公司、愛惜康公司、漢高股份公司、亨斯邁公司、邁圖高新材料公司、日電工株公司、Recticel 公司、亨斯邁公司、邁圖高新材料公司、日電工株式公司、Recticel 有限公司、Peusel 公司、Peus、TRT 公司、Peusel 公司、Peusel 公司工業產品公司、聖戈班公司、阿科瑪公司、伊士曼化學公司、路博潤公司、普立萬公司、Quadrant 股份公司、Rochling 集團、帝斯曼生物醫學、Invibio 有限公司、卡彭特技術公司、Heraezol 公司、卡彭特技術公司、卡彭特技術公司、弗利氏醫療組件、Ceramezol 公司、卡彭特技術公司、卡彭特技術公司、弗利氏醫療組件Inc.、美敦力公司、雅培實驗室、強生公司和西門子醫療股份公司。
2024年,亞太地區是醫療義肢材料市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。本醫療義肢材料市場分析報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。
醫用人工材料市場報告涉及的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。
醫用義肢材料市場涵蓋醫用塑膠、醫用泡棉、醫用薄膜、醫用彈性體和醫用黏合劑的銷售。該市場的價值指的是“出廠價”,即商品製造商或生產商銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。
Medical engineered materials, often referred to as biomaterials, denote substances that are specifically crafted to meet particular or customized criteria, aiming to interact with biological systems for therapeutic or diagnostic purposes in the field of medicine. Serving as a crucial link between science, technology, and medicine, these materials are employed to integrate essential elements of materials science with a deep understanding of medical design.
The principal categories of medical engineered materials include medical plastics, medical foams, medical films, medical adhesives, and medical elastomers. Medical-grade plastic materials are formulated to produce items for medical applications. These materials find use in the manufacturing of products for in vitro diagnostics and primary packaging for pharmaceuticals, ensuring the preservation and containment of medicines to prevent contamination. The diverse applications span medical devices, medical disposables, medical wearables, and advanced wound care.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The medical engineered materials market research report is one of a series of new reports from The Business Research Company that provides medical engineered materials market statistics, including medical engineered materials industry global market size, regional shares, competitors with a medical engineered materials market share, detailed medical engineered materials market segments, market trends and opportunities, and any further data you may need to thrive in the medical engineered materials industry. This medical engineered materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical engineered materials market size has grown rapidly in recent years. It will grow from $22.12 billion in 2024 to $25.24 billion in 2025 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to aging population, regulatory compliance, infection control, materials for implants, tissue engineering.
The medical engineered materials market size is expected to see rapid growth in the next few years. It will grow to $43.18 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to global health preparedness, 3D printing and additive manufacturing, advanced coatings, nanomedicine, personalized medicine. Major trends in the forecast period include nanotechnology, biodegradable and resorbable materials, bioactive and smart materials, sustainability and eco-friendly materials, advancements in medical technology.
The forecast of 14.4% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased duties on biocompatible titanium and polyether ether ketone (PEEK) polymers from Switzerland, slowing the production of implants and prosthetics while driving up healthcare costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated increase in chronic diseases is poised to propel the growth of the medical engineered materials market. Chronic diseases, characterized by lasting a year or more and requiring ongoing medical attention or limiting daily activities, are driving the demand for materials that can be engineered at the nano level. Nanoengineered components are utilized to construct miniature replicas of heart chambers, offering innovative solutions for treating heart-related issues. As indicated by the National Center for Biotechnology Information (NCBI) in January 2023, the global population with chronic diseases is projected to reach 142.66 million by 2050, a significant rise from 71.522 million in 2020. Hence, the escalating instances of chronic diseases serve as a catalyst for the growth of the medical engineered materials market.
The increasing number of surgical procedures is expected to be a driving force behind the growth of the medical engineered materials market. Surgical procedures involve medical interventions that necessitate incisions or invasive techniques to access and treat internal or external body areas. This surge in surgical procedures creates a heightened demand for materials used in surgical instruments, implantable devices, and minimally invasive procedures. The critical need for biocompatible and infection-resistant materials underscores their role in ensuring patient safety. Research and development driven by customization and regulatory standards, coupled with innovations in materials prompted by cost efficiency and technological advancements, contribute to the growth of the medical engineered materials market. For example, the Organization for Economic Co-operation and Development reported an 8.4% increase in cataract surgical procedures in the Czech Republic in October 2023, totaling 142,670 procedures in 2022 compared to 131,612 in 2021. Therefore, the rising number of surgical procedures acts as a growth driver for the medical engineered materials market.
Major players in the medical engineered materials market are strategically introducing new products to enhance their competitive position. An instance of this is Celanese Corporation, a US-based specialty materials company, launching Celanex MT PBT 2406MT GF20 in May 2022. This high-performance material is tailored for medical devices and various applications, offering exceptional strength, stiffness, and noise-free sliding capabilities. It finds applicability in Class I, Class II, and Class III medical device applications, as well as in automotive, electrical, electronics, industrial machinery, and consumer goods. The tribologically modified PBT+PET grade, reinforced with 20% glass fiber, provides versatile solutions across multiple industries.
Major companies in the medical engineered materials market are investing in the development of new products to gain a competitive edge. Covestro AG, a Germany-based polymer materials company, introduced Makrolon 3638 polycarbonate in February 2023. This advanced material solution, tailored for healthcare and life sciences applications, exhibits high durability across a wide temperature range, from cryogenic to steam sterilization conditions. It features high impact strength and ductility, along with high chemical resistance, meeting medical-grade and biocompatibility standards. Suitable for skin contact applications, the material is also of food contact quality and can be sterilized using common methods in the healthcare sector.
In February 2022, Celanese Corporation, a US-based global chemical leader, completed the acquisition of DuPont's resins and Advanced Solutions business lines for $11 billion. This strategic move is expected to position Celanese as a market leader with unparalleled scale, production capabilities, and technological expertise to cater to the automotive, consumer, and industrial markets. DuPont, a US-based company operating in medical engineered materials, is part of this acquisition.
Major companies operating in the medical engineered materials market include Evonik Industries AG, Covestro AG, BASF SE, Solvay SA, Saudi Basic Industries Corporation, Trelleborg AB, Koninklijke DSM N.V, Celanese Corporation, DuPont de Nemours Inc., Ethicon Inc., Henkel AG & Co. KGaA, Huntsman Corporation, Momentive Performance Materials Inc., Nitto Denko Corporation, Recticel Ltd., Victrex plc, Ensinger GmbH, RTP Company, Foster Corporation, Zeus Industrial Products Inc., Saint-Gobain SA, Arkema SA, Eastman Chemical Company, Lubrizol Corporation, PolyOne Corporation, Quadrant AG, Rochling Group, DSM Biomedical, Invibio Ltd., Carpenter Technology Corporation, Heraeus Medical Components GmbH, CeramTec GmbH, Morgan Advanced Materials plc, Freudenberg Medical LLC, Synectic Engineering Inc., Medtronic plc, Abbott Laboratories, Johnson & Johnson, Siemens Healthineers AG
Asia-Pacific was the largest region in the medical engineered materials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this medical engineered materials market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The countries covered in the medical engineered materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The medical engineered materials market consists of sales of medical plastics, medical foams, medical films, medical elastomers, and medical adhesives. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Engineered Materials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on medical engineered materials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical engineered materials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical engineered materials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.